Inhibrx Biosciences, Inc. — All Filings
114 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12B
10-12B/A
10-K
10-Q
3
4
424B3
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
POS EX
S-1
S-8
SC 13D
SC 13G
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF ACTION
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0002007919-26-000007 | Mar 19, 2026 | — |
| 10-K | 10-K | 0002007919-26-000006 | Mar 19, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0002007919-26-000002 | Feb 23, 2026 | — |
| SCHEDULE 13G/A | — | 0000905148-26-000883 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0002012383-26-000675 | Jan 21, 2026 | — |
| 8-K | 8-K | 0002007919-25-000097 | Dec 16, 2025 | — |
| 8-K | 8-K | 0002007919-25-000094 | Nov 14, 2025 | — |
| 10-Q | 10-Q | 0002007919-25-000093 | Nov 14, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0002007919-25-000089 | Oct 23, 2025 | — |
| SCHEDULE 13G/A | — | 0002012383-25-002589 | Oct 17, 2025 | — |
| 4 | — | 0000905148-25-003555 | Oct 9, 2025 | Oct 7, 2025 |
| 8-K | 8-K | 0002007919-25-000083 | Aug 13, 2025 | — |
| 10-Q | 10-Q | 0002007919-25-000081 | Aug 13, 2025 | Jun 30, 2025 |
| EFFECT | — | 9999999995-25-001825 | Jun 4, 2025 | — |
| POS AM | POS AM | 0002007919-25-000075 | Jun 2, 2025 | — |
| 4 | FORM 4 | 0002007919-25-000072 | May 29, 2025 | May 28, 2025 |
| 4 | FORM 4 | 0002007919-25-000070 | May 29, 2025 | May 28, 2025 |
| 4 | FORM 4 | 0002007919-25-000068 | May 29, 2025 | May 28, 2025 |
| 4 | FORM 4 | 0002007919-25-000066 | May 29, 2025 | May 28, 2025 |
| 424B3 | 424B3 | 0002007919-25-000064 | May 28, 2025 | — |
| 8-K | 8-K | 0002007919-25-000063 | May 28, 2025 | — |
| 424B3 | 424B3 | 0002007919-25-000059 | May 14, 2025 | — |
| 8-K | 8-K | 0002007919-25-000057 | May 14, 2025 | — |
| 10-Q | 10-Q | 0002007919-25-000056 | May 14, 2025 | Mar 31, 2025 |
| EFFECT | — | 9999999995-25-001146 | Apr 18, 2025 | — |
| POS AM | POS AM | 0002007919-25-000051 | Apr 17, 2025 | — |
| ARS | ARS | 0002007919-25-000048 | Apr 17, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0002007919-25-000045 | Apr 16, 2025 | — |
| DEF 14A | DEF 14A | 0002007919-25-000043 | Apr 16, 2025 | Dec 31, 2024 |
| 4 | FORM 4 | 0002007919-25-000037 | Apr 2, 2025 | Apr 1, 2025 |
| 4 | FORM 4 | 0002007919-25-000035 | Apr 2, 2025 | Apr 1, 2025 |
| 3 | FORM 3 | 0002007919-25-000033 | Apr 2, 2025 | Apr 1, 2025 |
| 424B3 | 424B3 | 0002007919-25-000031 | Apr 1, 2025 | — |
| 8-K | 8-K | 0002007919-25-000028 | Apr 1, 2025 | Mar 31, 2025 |
| 4 | FORM 4 | 0002007919-25-000025 | Mar 28, 2025 | Mar 27, 2025 |
| POS EX | POS EX | 0002007919-25-000023 | Mar 17, 2025 | — |
| 424B3 | 424B3 | 0002007919-25-000022 | Mar 17, 2025 | — |
| 8-K | 8-K | 0002007919-25-000020 | Mar 17, 2025 | — |
| 10-K | 10-K | 0002007919-25-000019 | Mar 17, 2025 | Dec 31, 2024 |
| SCHEDULE 13D/A | — | 0002007919-25-000015 | Feb 26, 2025 | — |
| SCHEDULE 13D/A | — | 0002007919-25-000012 | Feb 26, 2025 | — |
| SCHEDULE 13G | — | 0002012383-25-000635 | Feb 4, 2025 | — |
| 424B3 | 424B3 | 0002007919-25-000009 | Jan 21, 2025 | — |
| 8-K | 8-K | 0002007919-25-000007 | Jan 21, 2025 | — |
| 424B3 | 424B3 | 0002007919-25-000005 | Jan 13, 2025 | — |
| 8-K | 8-K | 0002007919-25-000003 | Jan 13, 2025 | — |
| 4 | FORM 4 | 0002007919-24-000068 | Dec 17, 2024 | Dec 16, 2024 |
| 4 | FORM 4 | 0002007919-24-000066 | Dec 6, 2024 | — |
| 4 | FORM 4 | 0002007919-24-000064 | Nov 22, 2024 | Nov 19, 2024 |
| SC 13G | SC 13G | 0001193125-24-259034 | Nov 14, 2024 | — |